Address: Andrés de Fuenzalida 22, of.1103 – Santiago de Chile
Tel: +56 2 335 4030
Laboratorio Kampar’s aim is to provide solutions and cures for complex diseases .The company initiated its operations as Laboratorio Kampar in 2005 by representing Laboratorios Kampel Martian de Argentina. previously existing through other companies since 1996. The company as it is today was financed by capital from Argentina, Chile and international investment funds.
Their main international commercial partners are LKM (Argentina), Medac (Germany), Helsinn (Switzerland), Gebro Pharma (Spain). All of the companies that they represent develop and produce their own product which are certified by the GMO, FDA or EMEA in their given production facilities. Within Chile they have established agreements with Grunenthal, Farmindustria and Volta.
Oncology
Sebastián Araya van der Schraft, General Manager at Laboratorio Kampar S.A. discusses the new medicine law in Chile—considered a victory by the last government—and further explains why Mexico is the…
Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at Heel, Loyola was part of a working group that is…
Medtronic, world’s largest medical technology company, opened a direct operation in Chile in October 2013. Gonzalo Valdebenito elaborates on the affiliate’s first steps in the country and the mission he…
Cells for Cells is the first Chilean biotechnology company engaged in the research, development and commercialization of innovative cell therapies based on adult stem cells. In line with the company’s…
“We have implemented a strategic plan with a key objective to put Chile on the map. We are seeing major market opportunities in the country”, says Carlos Cicogna, Managing Director,…
Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses the importance of the affiliate’s role in…
Raúl Sánchez, general manager of Peri Logistics speaks about the main features that distinguish Peri Logistics as a pharmaceutical logistics operator. Celebrating its 10th year anniversary this year, the company…
João Simões, Head of Integration at Grunenthal Chile, discusses Grunenthal’s acquisition of Andrómaco Laboratories. The acquisition has been a major step in Grunenthal’s growth strategy and has almost doubled its…
“70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart, Vicepresidente Ejecutivo of the association that represents the innovative…
Rodrigo Azócar Ibaceta, general manager at Laboratorios Raffo Chile speaks about Raffo’s development on the Chilean market. Part of the prestigious GP Pharm’s group, Raffo is one of the fastest…
Erich Viertel Molina, country manager at Janssen Chile speaks about Janssen’s commitment to the health of Chileans. Over the past years Janssen successfully launched several products to the Chilean market…
Pfizer will invest in a precision medical center studying new genome-based diagnostic technologies for cancer in Chile. It is the first center of excellence that Pfizer is building in Chile…
Our business model is new in the Chilean market and enables us with great flexibility and allows us to focus on demand generation. For Ferrer this is a great window…
See our Cookie Privacy Policy Here
